ArticleBiomedical engineering letters2025
Efficient sparse-view medical image classification for low radiation and rapid COVID-19 diagnosis.
Article in Biomedical engineering letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study proposes a deep learning-based diagnostic model called the Projection-wise Masked Autoencoder (ProMAE) for rapid and accurate COVID-19 diagnosis using sparse-view CT images. ProMAE employs a column-wise masking strategy during pre-training to effectively learn critical diagnostic features from sinograms, even under extremely sparse conditions. The trained ProMAE can directly classify sparse-view sinograms without requiring CT image reconstruction. Experiments on sparse-view data with 50%, 75%, 85%, 95%, and 99% sparsity show that ProMAE achieves a diagnostic accuracy of over 95% at all sparsity levels and, in particular, outperforms ResNet, ConvNeXt, and conventional MAE models in COVID-19 diagnosis in environments with 85% or higher sparsity. This capability is especially advantageous for the development of portable and flexible imaging systems during large-scale outbreaks such as COVID-19, as it ensures accurate diagnosis while minimizing radiation exposure, making it a vital tool in resource-limited and high-demand settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.